1379 related articles for article (PubMed ID: 15181052)
1. The prevalence and features of the polycystic ovary syndrome in an unselected population.
Azziz R; Woods KS; Reyna R; Key TJ; Knochenhauer ES; Yildiz BO
J Clin Endocrinol Metab; 2004 Jun; 89(6):2745-9. PubMed ID: 15181052
[TBL] [Abstract][Full Text] [Related]
2. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.
Ezeh U; Yildiz BO; Azziz R
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1088-96. PubMed ID: 23539721
[TBL] [Abstract][Full Text] [Related]
3. Is There a Difference in Hirsutism Score in Adolescents with Polycystic Ovary Syndrome on the Basis of Ethnicity and Race?
Badr F; Chattha AJ
J Pediatr Adolesc Gynecol; 2024 Jun; 37(3):348-352. PubMed ID: 38151058
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
[TBL] [Abstract][Full Text] [Related]
6. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
[TBL] [Abstract][Full Text] [Related]
7. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
J Clin Endocrinol Metab; 2006 Nov; 91(11):4237-45. PubMed ID: 16940456
[TBL] [Abstract][Full Text] [Related]
8. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
Fauser BC; Tarlatzis BC; Rebar RW; Legro RS; Balen AH; Lobo R; Carmina E; Chang J; Yildiz BO; Laven JS; Boivin J; Petraglia F; Wijeyeratne CN; Norman RJ; Dunaif A; Franks S; Wild RA; Dumesic D; Barnhart K
Fertil Steril; 2012 Jan; 97(1):28-38.e25. PubMed ID: 22153789
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome.
Ehrmann DA
N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
[No Abstract] [Full Text] [Related]
10. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
Dunaif A
Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, diagnosis, and management of polycystic ovary syndrome.
Sirmans SM; Pate KA
Clin Epidemiol; 2013 Dec; 6():1-13. PubMed ID: 24379699
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.
Teede H; Deeks A; Moran L
BMC Med; 2010 Jun; 8():41. PubMed ID: 20591140
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.
Goodarzi MO; Dumesic DA; Chazenbalk G; Azziz R
Nat Rev Endocrinol; 2011 Apr; 7(4):219-31. PubMed ID: 21263450
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
Legro RS; Arslanian SA; Ehrmann DA; Hoeger KM; Murad MH; Pasquali R; Welt CK;
J Clin Endocrinol Metab; 2013 Dec; 98(12):4565-92. PubMed ID: 24151290
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome.
Norman RJ; Dewailly D; Legro RS; Hickey TE
Lancet; 2007 Aug; 370(9588):685-97. PubMed ID: 17720020
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of polycystic ovarian syndrome in Indian adolescents.
Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):223-7. PubMed ID: 21600812
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
19. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
